JP Morgan Chase
OPK icon

JP Morgan Chase’s Opko Health OPK Stock Holding History

JP Morgan Chase’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Sell
168,305
-340,179
-67% -$434K ﹤0.01% 5490
2026
Q1 		$559K Sell
508,484
-71,294
-12% -$87.8K ﹤0.01% 4924
2025
Q4 		$731K Buy
579,778
+52,367
+10% +$72.9K ﹤0.01% 4799
2025
Q3 		$817K Sell
527,411
-102,944
-16% -$141K ﹤0.01% 4729
2025
Q2 		$832K Sell
630,355
-1,870,977
-75% -$2.56M ﹤0.01% 4497
2025
Q1 		$4.15M Buy
2,501,332
+926,361
+59% +$1.53M ﹤0.01% 3320
2024
Q4 		$2.32M Sell
1,574,971
-261,897
-14% -$400K ﹤0.01% 4036
2024
Q3 		$2.74M Buy
1,836,868
+537,026
+41% +$797K ﹤0.01% 3731
2024
Q2 		$1.62M Sell
1,299,842
-292,711
-18% -$380K ﹤0.01% 3951
2024
Q1 		$1.91M Sell
1,592,553
-351,784
-18% -$352K ﹤0.01% 3879
2023
Q4 		$2.94M Buy
1,944,337
+51,999
+3% +$75.2K ﹤0.01% 3539
2023
Q3 		$3.03M Sell
1,892,338
-502,683
-21% -$916K ﹤0.01% 3220
2023
Q2 		$5.2M Buy
2,395,021
+1,129,821
+89% +$1.77M ﹤0.01% 2825
2023
Q1 		$1.85M Sell
1,265,200
-13,618
-1% -$17.5K ﹤0.01% 3601
2022
Q4 		$1.6M Sell
1,278,818
-1,095,358
-46% -$1.73M ﹤0.01% 3732
2022
Q3 		$4.49M Buy
2,374,176
+344,713
+17% +$815K ﹤0.01% 2838
2022
Q2 		$5.13M Sell
2,029,463
-646,680
-24% -$1.89M ﹤0.01% 2778
2022
Q1 		$9.21M Buy
2,676,143
+463,047
+21% +$1.64M ﹤0.01% 2457
2021
Q4 		$10.6M Buy
2,213,096
+936,522
+73% +$3.79M ﹤0.01% 2396
2021
Q3 		$4.66M Buy
1,276,574
+369,649
+41% +$1.38M ﹤0.01% 3089
2021
Q2 		$3.67M Buy
906,925
+593,026
+189% +$2.33M ﹤0.01% 3314
2021
Q1 		$1.35M Buy
313,899
+61,408
+24% +$293K ﹤0.01% 4002
2020
Q4 		$998K Sell
252,491
-175,322
-41% -$732K ﹤0.01% 3967
2020
Q3 		$1.47M Buy
427,813
+280,496
+190% +$1.18M ﹤0.01% 3431
2020
Q2 		$502K Buy
147,317
+20,665
+16% +$46.3K ﹤0.01% 3849
2020
Q1 		$170K Sell
126,652
-138,050
-52% -$216K ﹤0.01% 4334
2019
Q4 		$389K Sell
264,702
-744,844
-74% -$1.25M ﹤0.01% 4366
2019
Q3 		$2.11M Buy
1,009,546
+260,729
+35% +$533K ﹤0.01% 3386
2019
Q2 		$1.66M Buy
748,817
+670,200
+852% +$1.46M ﹤0.01% 3503
2019
Q1 		$205K Sell
78,617
-6,540
-8% -$19.8K ﹤0.01% 4621
2018
Q4 		$256K Sell
85,157
-6,618
-7% -$22.4K ﹤0.01% 4475
2018
Q3 		$317K Sell
91,775
-14,818
-14% -$78.7K ﹤0.01% 4503
2018
Q2 		$501K Buy
106,593
+53,630
+101% +$203K ﹤0.01% 4176
2018
Q1 		$168K Buy
52,963
+11,996
+29% +$48.3K ﹤0.01% 4428
2017
Q4 		$201K Buy
40,967
+6,982
+21% +$40.5K ﹤0.01% 4410
2017
Q3 		$236K Buy
33,985
+33,799
+18,172% +$213K ﹤0.01% 4058
2017
Q2 		$1K Sell
186
-5,402
-97% -$37.9K ﹤0.01% 4885
2017
Q1 		$44K Buy
5,588
+5,355
+2,298% +$45.1K ﹤0.01% 4560
2016
Q4 		$2K Sell
233
-240
-51% -$2.48K ﹤0.01% 4940
2016
Q3 		$5K Sell
473
-6,157
-93% -$61.3K ﹤0.01% 4369
2016
Q2 		$62K Buy
6,630
+867
+15% +$8.8K ﹤0.01% 3995
2016
Q1 		$60K Sell
5,763
-4,964
-46% -$45.4K ﹤0.01% 3858
2015
Q4 		$107K Buy
10,727
+8,452
+372% +$84.7K ﹤0.01% 3773
2015
Q3 		$19K Buy
+2,275
New +$30.1K ﹤0.01% 3837
2013
Q4 		– Sell
-228,252
Closed -$2.01M – 4193
2013
Q3 		$2.01M Buy
228,252
+93,963
+70% +$754K ﹤0.01% 2802
2013
Q2 		$953K Buy
+134,289
New +$927K ﹤0.01% 3289

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase's OPK Position: Q2 2026 in Review

JP Morgan Chase reduced its Opko Health (OPK) stake by 67% in Q2 2026, selling an estimated $434K and leaving 168,305 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #5490.

JP Morgan Chase first reported a position in OPK in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.6M in Q4 2021. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • JP Morgan Chase held 168,305 shares of Opko Health worth $254K as of Q2 2026.
  • JP Morgan Chase sold 340,179 Opko Health shares in Q2 2026, an estimated $434K.
  • Opko Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5490 holding.
  • JP Morgan Chase first reported a position in Opko Health in Q2 2013 and has held it in 46 quarters since.
  • JP Morgan Chase's Opko Health position peaked at $10.6M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.